Home / XCUR : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does XCUR make money? Does XCUR have pricing power? What's the Earnings Whisper? Will XCUR profit more as the business scales? What is XCUR's management track record? Is XCUR's current price justified?

Exicure, Inc.

$1.4 -$4.18 (-74.83%)

NASDAQ · 14 Sep 2026 14:19 UTC

Previous Close

$1.4

Day Range

$1.35$1.4

Year Range

$1.05$9.48

Market Cap

8.95M

AVG Volume

402.53K

Trailing/Forward PE

-0.95/-

PEG ratio

0.01

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

NASDAQ

Revenue (USD)

XCUR Revenue (USD) by year
Period	Revenue (USD)
2025	0
2024	500K
2023	0
2022	28.83M
2021	-483K
2020	16.61M
2019	1.3M
2018	118K
2017	9.72M
2016	1.04M

Net Income (USD)

XCUR Net Income (USD) by year
Period	Net Income (USD)
2025	-4.95M
2024	-9.7M
2023	-16.91M
2022	-2.58M
2021	-64.1M
2020	-24.67M
2019	-26.3M
2018	-22.41M
2017	-10.67M
2016	-16.94M

Operating Income (USD)

XCUR Operating Income (USD) by year
Period	Operating Income (USD)
2025	-4.21M
2024	-12.23M
2023	-15M
2022	-1.83M
2021	-62.55M
2020	-25.44M
2019	-26.62M
2018	-21.82M
2017	-10.07M
2016	-16.16M

EBITDA (USD)

XCUR EBITDA (USD) by year
Period	EBITDA (USD)
2025	-10.98M
2024	-8.85M
2023	-15.54M
2022	-446K
2021	-61.38M
2020	-23.36M
2019	-25.2M
2018	-21.38M
2017	-9.81M
2016	-16.03M

Cash Flows (USD)

XCUR Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-8.56M
2024	-2.91M
2023	-10.36M
2022	-36.17M
2021	-35.79M
2020	-42.44M
2019	235K
2018	-19.58M
2017	-20.71M
2016	-5.44M

EPS (USD)

XCUR EPS (USD) by year
Period	EPS (USD)
2025	-0.76
2024	-1.51
2023	-2.12
2022	-1.07
2021	-21.81
2020	-8.57
2019	-13.69
2018	-16.44
2017	-8.09
2016	-12.89

Expenses (USD)

XCUR Expenses (USD) by year
Period	Expenses (USD)
2025	10.12M
2024	5.45M
2023	13.14M
2022	30.67M
2021	63.03M
2020	45.22M
2019	28.99M
2018	22.03M
2017	20.71M
2016	17.59M

Cash & Debt (USD)

XCUR Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	3.75M
2024	12.51M
2023	816K
2022	8.58M
2021	39.14M
2020	82.08M
2019	110.79M
2018	26.27M
2017	25.76M
2016	19.62M

Debt ratios

XCUR Debt ratios by year
Period	Debt ratios
2025	0.1
2024	0.08
2023	-0.06
2022	0.01
2021	0.19
2020	0.72
2019	1.46

Margins

XCUR Margins by year
Period	Margins
2024	100%
2022	56.2%
2021	10240.58%
2020	-1.61%
2019	-1392.28%
2018	-11865.25%
2017	-34.58%
2016	-1218.44%

Return on Capital

XCUR Return on Capital by year
Period	Return on Capital
2025	-125.98%
2024	-143.25%
2023	-558.03%
2022	-17.3%
2021	-570.71%
2020	-40.11%
2019	-32.57%
2018	-106.97%
2017	-53.42%
2016	-692.03%

Shares Outstanding

XCUR Shares Outstanding by year
Period	Shares Outstanding
2025	6.3M
2024	6.03M
2023	8.65M
2022	4.97M
2021	2.95M
2020	2.91M
2019	2.57M
2018	1.48M
2017	1.33M
2016	1.31M

Book Value Per Share (USD)

XCUR Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.62
2024	1.12
2023	0.35
2022	3
2021	3.8
2020	21.15
2019	31.42
2018	14.16
2017	15.01
2016	1.87

Total Assets (USD)

XCUR Total Assets (USD) by year
Period	Total Assets (USD)
2025	14.04M
2024	15.06M
2023	11.58M
2022	23.33M
2021	64.87M
2020	100.44M
2019	115.26M
2018	28.76M
2017	28.99M
2016	20.58M

Employee Count

XCUR Employee Count by year
Period	Employee Count
2025	8
2024	7
2023	6
2022	13
2021	47
2020	63
2019	29
2018	27
2017	23

PE Ratio

XCUR PE Ratio by year
Period	PE Ratio
May 24	37.65
May 24	27.99
May 24	42.06

Free Cash Flow Yield

XCUR Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-71.55%
Sep 26	-80.14%
Aug 26	-77.65%
Aug 26	-87.11%
Aug 26	-80.14%
Aug 26	-94.13%
Jul 26	-79.43%
Jul 26	-72.2%
Jul 26	-75.64%
Jul 26	-72.62%
Jul 26	-66.53%
Jun 26	-52.95%
Jun 26	-55.01%
Jun 26	-45.71%
Jun 26	-43.52%
May 26	-39.84%
May 26	-48.35%
May 26	-47.84%
May 26	-40.32%
May 26	-41.94%
Apr 26	-39.16%
Apr 26	-35.85%
Apr 26	-35.95%
Apr 26	-32.43%
Mar 26	-30.74%
Mar 26	-30.1%
Mar 26	-31.89%
Mar 26	-32.27%
Feb 26	-35.81%
Feb 26	-37.41%
Feb 26	-32.83%
Feb 26	-33.23%
Jan 26	-32.91%
Jan 26	-21.74%
Jan 26	-21.53%
Jan 26	-22.93%
Jan 26	-24%
Dec 25	-22.36%
Dec 25	-22.62%
Dec 25	-21.09%
Dec 25	-27.33%
Nov 25	-32.04%
Nov 25	-32.12%
Nov 25	-36.1%
Nov 25	-33.82%
Oct 25	-19.76%
Oct 25	-17.39%
Oct 25	-19.15%
Oct 25	-17.57%
Oct 25	-20.85%
Sep 25	-22.82%
Sep 25	-22.65%
Sep 25	-22.41%
Sep 25	-18.31%
Aug 25	-15.5%
Aug 25	-14.28%
Aug 25	-13.08%
Aug 25	-11.67%
Aug 25	-9.54%
Jul 25	-8.38%
Jul 25	-8.29%
Jul 25	-9.04%
Jul 25	-9.7%
Jun 25	-11.16%
Jun 25	-6.46%
Jun 25	-5.51%
Jun 25	-4.47%
May 25	-4.89%
May 25	-4.81%
May 25	-4.8%
May 25	-4.22%
May 25	-4.5%
Apr 25	-4.47%
Apr 25	-5.72%
Apr 25	-4.17%
Apr 25	-3.71%
Mar 25	-3.45%
Mar 25	-3.44%
Mar 25	-3.06%
Mar 25	-3.38%
Feb 25	-4.15%
Feb 25	-4.59%
Feb 25	-3.91%
Feb 25	-3.81%
Jan 25	-3.5%
Jan 25	-3.27%
Jan 25	-3.9%
Jan 25	-4.15%
Jan 25	-2.73%
Dec 24	-2.23%
Dec 24	-2.1%
Dec 24	-2.27%
Dec 24	-1.62%
Nov 24	-1.33%
Nov 24	-2.14%
Nov 24	-13.54%
Nov 24	-30.44%
Nov 24	-26.49%
Oct 24	-35.33%
Oct 24	-31.24%

Price to Sales

XCUR Price to Sales by year
Period	Price to Sales
Jun 25	90.04
Jun 25	105.71
Jun 25	130.18
May 25	118.97
May 25	121.02
May 25	121.26
May 25	137.89
May 25	129.34
Apr 25	130.18
Apr 25	101.73
Apr 25	139.58
Apr 25	156.7
Mar 25	168.63
Mar 25	169.35
Mar 25	188.32
Mar 25	170.26
Feb 25	138.71
Feb 25	125.5
Feb 25	147.22
Feb 25	151.18
Jan 25	164.83
Jan 25	176.43
Jan 25	147.81
Jan 25	138.85
Jan 25	210.77
Dec 24	258.04
Dec 24	274.04
Dec 24	254.07
Dec 24	355.94
Nov 24	432.85
Nov 24	269.78
Nov 24	42.57
Nov 24	47.58
Nov 24	54.67
Oct 24	41.01
Oct 24	46.37
Oct 24	46.37
Oct 24	46.72
Sep 24	62.98
Sep 24	73.19
Sep 24	27.68
Sep 24	30.11
Aug 24	34.09
Aug 24	36.33
Aug 24	31.14
Aug 24	45.85
Aug 24	57.27
Jul 24	41.52
Jul 24	46.37
Jul 24	28.55
Jul 24	26.13
Jun 24	27.68
Jun 24	29.41
May 24	0.73
May 24	0.54
May 24	0.82
May 24	0.39
May 24	0.43
Apr 24	0.43
Apr 24	0.48
Apr 24	0.5
Apr 24	0.48
Mar 24	0.52
Mar 24	0.54
Mar 24	0.57
Mar 24	0.57
Mar 24	0.64
Feb 24	0.53
Feb 24	0.52
Feb 24	0.51
Feb 24	0.47
Jan 24	0.45
Jan 24	0.52
Jan 24	0.72
Jan 24	0.5
Dec 23	0.5
Dec 23	0.54
Dec 23	0.5
Dec 23	0.45
Dec 23	0.4
Nov 23	0.43
Nov 23	0.51
Nov 23	0.51
Nov 23	0.54
Oct 23	0.55
Oct 23	0.57
Oct 23	0.64
Oct 23	0.62
Sep 23	0.62
Sep 23	0.65
Sep 23	0.8
Sep 23	0.7
Sep 23	0.78
Aug 23	0.72
Aug 23	0.72
Aug 23	0.73
Aug 23	0.82
Jul 23	0.92
Jul 23	0.93
Jul 23	1.17

EV/EBITDA

XCUR EV/EBITDA by year
Period	EV/EBITDA
May 24	13.12
May 24	10.54
May 24	14.29

Price/Operating Cashflow

XCUR Price/Operating Cashflow by year
Period	Price/Operating Cashflow
May 20	749.21
May 20	547.27
Apr 20	638
Apr 20	599.95
Apr 20	570.69
Apr 20	398.02
Mar 20	386.31
Mar 20	301.44
Mar 20	348.27

Price to Book

XCUR Price to Book by year
Period	Price to Book
Sep 26	9.13
Sep 26	8.15
Aug 26	8.42
Aug 26	7.5
Aug 26	8.15
Aug 26	4.1
Jul 26	4.86
Jul 26	5.35
Jul 26	5.1
Jul 26	5.32
Jul 26	5.8
Jun 26	7.29
Jun 26	7.02
Jun 26	8.45
Jun 26	8.87
May 26	9.69
May 26	4.51
May 26	4.56
May 26	5.41
May 26	5.2
Apr 26	5.57
Apr 26	6.08
Apr 26	6.06
Apr 26	6.72
Mar 26	7.09
Mar 26	4.06
Mar 26	3.83
Mar 26	3.79
Feb 26	3.41
Feb 26	3.27
Feb 26	3.72
Feb 26	3.68
Jan 26	3.71
Jan 26	5.62
Jan 26	5.68
Jan 26	5.33
Jan 26	5.09
Dec 25	5.47
Dec 25	5.4
Dec 25	5.8
Dec 25	4.47
Nov 25	3.81
Nov 25	3.81
Nov 25	3.39
Nov 25	3.61
Oct 25	3.14
Oct 25	3.56
Oct 25	3.24
Oct 25	3.53
Oct 25	2.97
Sep 25	2.72
Sep 25	2.74
Sep 25	2.77
Sep 25	3.39
Aug 25	4
Aug 25	4.34
Aug 25	4.74
Aug 25	5.31
Aug 25	3.74
Jul 25	4.26
Jul 25	4.3
Jul 25	3.94
Jul 25	3.68
Jun 25	3.19
Jun 25	6.65
Jun 25	7.8
Jun 25	9.61
May 25	8.78
May 25	8.94
May 25	8.95
May 25	10.18
May 25	9.55
Apr 25	9.61
Apr 25	7.51
Apr 25	10.31
Apr 25	11.57
Mar 25	12.45
Mar 25	12.5
Mar 25	60.94
Mar 25	55.1
Feb 25	44.89
Feb 25	40.61
Feb 25	47.64
Feb 25	48.93
Jan 25	53.34
Jan 25	57.1
Jan 25	47.83
Jan 25	44.94
Jan 25	68.21
Dec 24	83.51
Dec 24	88.69
Dec 24	82.22
Dec 24	115.19
Nov 24	140.08
Nov 24	87.31
Nov 24	13.78
Nov 24	14.75
Nov 24	16.95
Oct 24	12.71
Oct 24	14.37

No video analysis for this stock yet. Request one from our team.

News: XCUR

globenewswire.com · 3 Aug 2026

Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance

WILMINGTON, Del., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics, Inc. (“GPCR Therapeutics”) during August 2026 in settlement of a $1.0 million clinical milestone payment obligation under the parties' License and Collaboration Agreement.

globenewswire.com · 30 Jun 2026

Exicure Announces Board and Committee Changes

WILMINGTON, Del., June 30, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company") today announced changes to its Board of Directors and Board committees following actions approved by the Company's Board of Directors at its special meeting held on June 24, 2026.

AI Analysis

Exicure, Inc.

Video analysis: XCUR

News: XCUR

Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance

Exicure Announces Board and Committee Changes

Similar companies